LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven LE GOUILL, PhD
Institut Curie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Amiens
Amiens, France
- Chu Angers
Angers, France
- Ch Côte Basque
Bayonne, France
- Chu Besançon
Besançon, France
- Institut Bergonié
Bordeaux, France
- Chu Caen
Caen, France
- Chu Clermont-Ferrand
Clermont-Ferrand, France
- Ch Colmar
Colmar, France
- Chu Créteil
Créteil, France
- Chu Dijon
Dijon, France
- Chu Grenoble
Grenoble, France
- Chru Lille
Lille, France
- Chu Limoges
Limoges, France
- Chu Lyon
Lyon, France
- Chu la Timone Marseille
Marseille, France
- Chu Nancy
Nancy, France
- Chu Nantes
Nantes, France
- Centre Lacassagne
Nice, France
- Chu Nîmes - Carémeau
Nîmes, France
- Chu Pitié-Salpêtrière
Paris, France
- Hôpital Cochin
Paris, France
- Institut Curie
Paris, France
- Chu Poitiers
Poitiers, France
- Chu Rennes
Rennes, France
- Centre Henri Becquerel
Rouen, France
- Chu Strasbourg-Hôpital Hautepierre
Strasbourg, France
- Iuct -Oncopole
Toulouse, France
- Chu Tours
Tours, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2020
- Primary completion
- 2 Feb 2035
- Completion
- 30 Aug 2035
- Last update posted
- 25 Sept 2025
- Registered enrollment
- 118
- Registry id
- NCT04446962
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.